Logo image of CRBK.CA

CAREBOOK TECHNOLOGIES INC (CRBK.CA) Stock Fundamental Analysis

TSX-V:CRBK - TSX Venture Exchange - CA14168C1023 - Common Stock - Currency: CAD

0.095  0 (0%)

Fundamental Rating

2

CRBK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 8 industry peers in the Health Care Technology industry. Both the profitability and financial health of CRBK have multiple concerns. CRBK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CRBK has reported negative net income.
In the past year CRBK had a positive cash flow from operations.
CRBK had negative earnings in each of the past 5 years.
In the past 5 years CRBK always reported negative operating cash flow.
CRBK.CA Yearly Net Income VS EBIT VS OCF VS FCFCRBK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

CRBK has a Return On Assets of -46.50%. This is comparable to the rest of the industry: CRBK outperforms 57.14% of its industry peers.
Industry RankSector Rank
ROA -46.5%
ROE N/A
ROIC N/A
ROA(3y)-103.67%
ROA(5y)-97.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRBK.CA Yearly ROA, ROE, ROICCRBK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 -100 200 -200 -300

1.3 Margins

With a decent Gross Margin value of 80.86%, CRBK is doing good in the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Gross Margin of CRBK has declined.
The Profit Margin and Operating Margin are not available for CRBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5YN/A
CRBK.CA Yearly Profit, Operating, Gross MarginsCRBK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

CRBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRBK has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CRBK has a worse debt to assets ratio.
CRBK.CA Yearly Shares OutstandingCRBK.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CRBK.CA Yearly Total Debt VS Total AssetsCRBK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

CRBK has an Altman-Z score of -12.60. This is a bad value and indicates that CRBK is not financially healthy and even has some risk of bankruptcy.
CRBK's Altman-Z score of -12.60 is in line compared to the rest of the industry. CRBK outperforms 42.86% of its industry peers.
CRBK has a debt to FCF ratio of 27.59. This is a negative value and a sign of low solvency as CRBK would need 27.59 years to pay back of all of its debts.
CRBK has a better Debt to FCF ratio (27.59) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 27.59
Altman-Z -12.6
ROIC/WACCN/A
WACC9.13%
CRBK.CA Yearly LT Debt VS Equity VS FCFCRBK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

CRBK has a Current Ratio of 0.36. This is a bad value and indicates that CRBK is not financially healthy enough and could expect problems in meeting its short term obligations.
CRBK's Current ratio of 0.36 is on the low side compared to the rest of the industry. CRBK is outperformed by 71.43% of its industry peers.
A Quick Ratio of 0.36 indicates that CRBK may have some problems paying its short term obligations.
CRBK has a worse Quick ratio (0.36) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
CRBK.CA Yearly Current Assets VS Current LiabilitesCRBK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

CRBK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.02%, which is quite impressive.
CRBK shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.28%.
The Revenue has been growing by 51.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)80.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.84%
Revenue 1Y (TTM)29.28%
Revenue growth 3Y51.42%
Revenue growth 5YN/A
Sales Q2Q%2.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.78%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRBK.CA Yearly Revenue VS EstimatesCRBK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 5M 10M
CRBK.CA Yearly EPS VS EstimatesCRBK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 -0.1 -0.2 -0.3 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CRBK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRBK.CA Price Earnings VS Forward Price EarningsCRBK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than CRBK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.92
EV/EBITDA N/A
CRBK.CA Per share dataCRBK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRBK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAREBOOK TECHNOLOGIES INC

TSX-V:CRBK (2/18/2025, 7:00:00 PM)

0.095

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-15 2024-11-15/amc
Earnings (Next)03-31 2025-03-31/amc
Inst Owners59.43%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap7.39M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.23%
Min Revenue beat(2)-4.52%
Max Revenue beat(2)4.98%
Revenue beat(4)3
Avg Revenue beat(4)2.82%
Min Revenue beat(4)-4.52%
Max Revenue beat(4)6.19%
Revenue beat(8)5
Avg Revenue beat(8)0.49%
Revenue beat(12)7
Avg Revenue beat(12)6.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF 21.92
P/OCF 21.92
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0
FCFY4.56%
OCF(TTM)0
OCFY4.56%
SpS0.19
BVpS-0.11
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.86%
FCFM 2.34%
ROA(3y)-103.67%
ROA(5y)-97.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5YN/A
F-Score5
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 27.59
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -12.6
F-Score5
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)5.25%
Cap/Depr(5y)7.14%
Cap/Sales(3y)1.03%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.84%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.28%
Revenue growth 3Y51.42%
Revenue growth 5YN/A
Sales Q2Q%2.41%
Revenue Next Year17.78%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year218.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y114.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y109.56%
OCF growth 3YN/A
OCF growth 5YN/A